Get started
Advisor Managed Portfolios Regan Fixed Rate MBS ETFAdvisor Managed Portfolios Regan Fixed Rate MBS ETFAdvisor Managed Portfolios Regan Fixed Rate MBS ETF

Advisor Managed Portfolios Regan Fixed Rate MBS ETF

No trades
See on Supercharts
Overview
Analysis Holdings Discussions

MBSX chart


Full chart

Key stats


Assets under management (AUM)
‪8.82 M‬ USD
Fund flows (1Y)
‪8.78 M‬ USD
Dividend yield (indicated)
—
Discount/Premium to NAV
0.04%
Shares outstanding
‪350.00 K‬
Expense ratio
0.40%

About Advisor Managed Portfolios Regan Fixed Rate MBS ETF


Issuer
Regan Capital LLC
Brand
Regan
Home page
reganfunds.com
Inception date
May 1, 2025
Structure
Open-Ended Fund
Index tracked
No Underlying Index
Management style
Active
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Regan Capital LLC
Distributor
Quasar Distributors LLC
MBSX actively invests in mortgage-backed securities (MBS), focusing on fixed rate agency residential MBS issued by government-sponsored entities, considered investment grade. Cash awaiting investment may be held in short-term investment vehicles like US government and agency securities, investment grade money market instruments, and equivalents. The fund invests in securities regardless of maturity or duration. The funds advisor seeks advantageous risk-return profiles, using bottom-up analysis of collateral and capital structures to identify value investments and trading opportunities.

Classification


Asset Class
Fixed income
Category
Government, mortgage-backed
Focus
Investment grade
Niche
Broad maturities
Strategy
Active
Geography
U.S.
Weighting scheme
Proprietary
Selection criteria
Proprietary

MBSX analysis


What's in the fund
Exposure type
Bonds, Cash & Other
Cash
Mutual fund
Securitized
Bonds, Cash & Other100.00%
Cash43.13%
Mutual fund35.58%
Securitized21.29%
Top 10 holdings

Broaden your horizons with more funds linked to MBSX via country, focus, and more.